Case: Patents/Obviousness (P.T.A.B.)

June 5, 2026, 7:47 PM UTC

The Patent Trial and Appeal Board held that challenged claims of Miracor Medical SA’s patent that relates to medical care for normalizing and stabilizing cardiac function after a heart failure are unpatentable as obvious over prior art, in an inter partes review by Abbott Laboratories. The board determined that the challenged claims are obvious over prior art that relates to a rotary pump for moving blood and other shear-sensitive liquids with a rotor journaled hydraulically and that relates to a study describing recent progress in the development of the T-ILVAS. And the board denied Miracor’s motion to exclude evidence.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.